Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-20

FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Dr. Reddys Laboratories Inc)

View source ↗

Summary

The FDA approved a supplemental application for Abiraterone Acetate from Dr. Reddy's Laboratories Inc, enabling a generic version of the drug to be marketed for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)